Division of Radiation Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
Med Oncol. 2020 Aug 17;37(10):85. doi: 10.1007/s12032-020-01409-2.
Management of patients with head and neck cancers (HNCs) is challenging for the Radiation Oncologist, especially in the COVID-19 era. The Italian Society of Radiotherapy and Clinical Oncology (AIRO) identified the need of practice recommendations on logistic issues, treatment delivery and healthcare personnel's protection in a time of limited resources. A panel of 15 national experts on HNCs completed a modified Delphi process. A five-point Likert scale was used; the chosen cut-offs for strong agreement and agreement were 75% and 66%, respectively. Items were organized into two sections: (1) general recommendations (10 items) and (2) special recommendations (45 items), detailing a set of procedures to be applied to all specific phases of the Radiation Oncology workflow. The distribution of facilities across the country was as follows: 47% Northern, 33% Central and 20% Southern regions. There was agreement or strong agreement across the majority (93%) of proposed items including treatment strategies, use of personal protection devices, set-up modifications and follow-up re-scheduling. Guaranteeing treatment delivery for HNC patients is well-recognized in Radiation Oncology. Our recommendations provide a flexible tool for management both in the pandemic and post-pandemic phase of the COVID-19 outbreak.
管理头颈部癌症(HNCs)患者对放射肿瘤学家来说具有挑战性,尤其是在 COVID-19 时代。意大利放射治疗和临床肿瘤学会(AIRO)确定了在资源有限的情况下就后勤问题、治疗实施以及医务人员防护提供实践建议的必要性。一个由 15 名 HNC 领域的国家专家组成的小组完成了一项改良德尔菲法研究。使用了 5 点李克特量表;强烈同意和同意的选择截止值分别为 75%和 66%。项目被分为两部分:(1)一般建议(10 项)和(2)特殊建议(45 项),详细说明了一套将应用于放射肿瘤学工作流程所有特定阶段的程序。全国各地的设施分布情况如下:北部 47%、中部 33%和南部 20%。包括治疗策略、使用个人防护设备、设置修改和随访重新安排在内的大多数(93%)建议都得到了一致或强烈的同意。为 HNC 患者提供治疗保障在放射肿瘤学领域得到了广泛认可。我们的建议为 COVID-19 爆发的大流行和大流行后阶段的管理提供了一个灵活的工具。